Stock listing
Stockholm:HNSA Hansa Biopharma AB Aktie
Home listing (Stockholm) of Hansa Biopharma AB
Follow Hansa Biopharma AB into a list and get an email when it puts out news.
Share price · OMXSTO:HNSA
38.22 SEK +2.22 (+6.2%)
Close on Oct 20, 2026
- Day range
- 35.86 – 38.22 SEKOct 20, 2026
- Volume
- 283,695 sharesOct 20, 2026
- Market cap
- 3.81B SEKAt the close on Oct 20, 2026 · price × 99.73M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:HNSA · Home | 38.22 SEK | +2.22 (+6.2%) | 283,695 | 36.10 | 38.22 | 35.86 | 36.00 | Close on Oct 20, 2026 |
| Frankfurt:24H | €3.35 EUR | +0.232 (+7.4%) | — | €3.112 | €3.35 | €3.112 | €3.118 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · OMXSTO:HNSA · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 38.22 | +2.22 | +6.2% | 36.10 | 38.22 | 35.86 | 283,695 | |
| 36.00 | +0.10 | +0.3% | 35.90 | 36.14 | 35.26 | 164,385 | |
| 35.90 | -0.54 | -1.5% | 36.70 | 37.24 | 35.90 | 282,656 | |
| 36.44 | +1.20 | +3.4% | 35.14 | 36.66 | 34.80 | 459,001 | |
| 35.24 | +0.62 | +1.8% | 34.88 | 35.52 | 34.24 | 189,733 | |
| 34.62 | -1.50 | -4.2% | 36.48 | 36.74 | 34.62 | 366,019 | |
| 36.12 | +0.16 | +0.4% | 36.20 | 36.68 | 34.84 | 367,385 | |
| 35.96 | +2.58 | +7.7% | 33.68 | 36.10 | 33.68 | 508,287 | |
| 33.38 | -0.46 | -1.4% | 33.84 | 34.00 | 33.14 | 346,447 | |
| 33.84 | 0.00 | 0.0% | 33.60 | 34.20 | 33.40 | 232,643 | |
| 33.84 | +0.62 | +1.9% | 33.22 | 34.20 | 32.84 | 378,828 | |
| 33.22 | +0.04 | +0.1% | 33.16 | 33.98 | 33.10 | 297,478 | |
| 33.18 | -0.94 | -2.8% | 34.10 | 34.40 | 33.00 | 431,147 | |
| 34.12 | +0.62 | +1.9% | 34.06 | 34.94 | 33.52 | 639,938 | |
| 33.50 | +1.00 | +3.1% | 32.86 | 33.76 | 32.60 | 567,304 | |
| 32.50 | -1.00 | -3.0% | 33.52 | 33.58 | 32.50 | 538,260 | |
| 33.50 | +1.14 | +3.5% | 32.36 | 34.84 | 32.28 | 1,443,049 | |
| 32.36 | +0.14 | +0.4% | 32.60 | 32.76 | 31.62 | 1,131,469 | |
| 32.22 | -1.78 | -5.2% | 34.16 | 34.16 | 32.12 | 909,549 | |
| 34.00 | -1.66 | -4.7% | 35.72 | 35.86 | 34.00 | 554,191 | |
| 35.66 | -0.54 | -1.5% | 36.22 | 36.48 | 35.24 | 494,541 | |
| 36.20 | -0.42 | -1.1% | 36.72 | 36.98 | 35.90 | 413,243 | |
| 36.62 | -1.62 | -4.2% | 38.20 | 38.52 | 36.54 | 546,171 | |
| 38.24 | +0.28 | +0.7% | 38.06 | 38.98 | 36.90 | 494,472 | |
| 37.96 | +0.14 | +0.4% | 38.12 | 38.44 | 37.54 | 343,772 | |
| 37.82 | -1.94 | -4.9% | 39.76 | 39.76 | 37.42 | 669,209 | |
| 39.76 | -0.74 | -1.8% | 40.10 | 42.22 | 39.24 | 536,666 | |
| 40.50 | -1.46 | -3.5% | 42.04 | 42.04 | 40.46 | 481,774 | |
| 41.96 | -1.64 | -3.8% | 43.60 | 44.02 | 41.68 | 468,060 | |
| 43.60 | -2.60 | -5.6% | 45.70 | 46.04 | 43.50 | 563,918 | |
| 46.20 | +0.04 | +0.1% | 46.16 | 46.84 | 45.02 | 407,432 | |
| 46.16 | -0.10 | -0.2% | 45.72 | 46.48 | 45.20 | 374,918 | |
| 46.26 | +1.76 | +4.0% | 44.50 | 46.48 | 43.80 | 824,429 | |
| 44.50 | -2.18 | -4.7% | 46.44 | 47.70 | 44.50 | 837,431 | |
| 46.68 | +3.90 | +9.1% | 42.40 | 48.22 | 42.26 | 1,219,037 | |
| 42.78 | -0.42 | -1.0% | 43.30 | 43.80 | 41.58 | 647,966 | |
| 43.20 | -1.34 | -3.0% | 44.56 | 44.78 | 43.20 | 376,489 | |
| 44.54 | +0.36 | +0.8% | 44.48 | 46.60 | 44.28 | 632,555 | |
| 44.18 | +1.14 | +2.6% | 43.06 | 44.18 | 42.24 | 472,336 | |
| 43.04 | -0.26 | -0.6% | 43.80 | 44.80 | 42.90 | 622,044 | |
| 43.30 | +1.46 | +3.5% | 42.16 | 43.30 | 41.82 | 423,567 | |
| 41.84 | +0.10 | +0.2% | 41.80 | 42.50 | 40.76 | 550,477 | |
| 41.74 | +1.10 | +2.7% | 41.00 | 41.94 | 40.22 | 538,970 | |
| 40.64 | -1.06 | -2.5% | 41.86 | 42.66 | 40.48 | 349,519 | |
| 41.70 | -0.04 | -0.1% | 41.88 | 42.20 | 40.26 | 541,583 | |
| 41.74 | -0.16 | -0.4% | 41.86 | 43.58 | 41.44 | 813,575 | |
| 41.90 | +2.74 | +7.0% | 39.46 | 41.98 | 39.46 | 735,836 | |
| 39.16 | -1.20 | -3.0% | 40.48 | 41.34 | 39.00 | 588,504 | |
| 40.36 | -0.66 | -1.6% | 41.22 | 41.78 | 40.36 | 374,054 | |
| 41.02 | +0.54 | +1.3% | 40.52 | 41.08 | 39.36 | 423,133 | |
| 40.48 | +0.86 | +2.2% | 39.88 | 41.48 | 39.52 | 443,348 | |
| 39.62 | -1.10 | -2.7% | 41.00 | 41.90 | 39.30 | 710,968 | |
| 40.72 | +2.88 | +7.6% | 37.84 | 41.10 | 37.68 | 1,213,227 | |
| 37.84 | +3.42 | +9.9% | 34.34 | 38.98 | 34.02 | 2,043,808 | |
| 34.42 | +1.02 | +3.1% | 33.42 | 34.50 | 32.42 | 863,575 | |
| 33.40 | +0.14 | +0.4% | 33.16 | 34.10 | 33.00 | 490,111 | |
| 33.26 | -1.14 | -3.3% | 34.70 | 34.88 | 32.76 | 819,094 | |
| 34.40 | +0.10 | +0.3% | 34.30 | 35.74 | 33.32 | 756,119 | |
| 34.30 | -2.02 | -5.6% | 35.94 | 35.94 | 34.00 | 1,231,346 | |
| 36.32 | -0.74 | -2.0% | 37.14 | 38.30 | 36.26 | 669,374 | |
| 37.06 | -0.78 | -2.1% | 37.86 | 38.88 | 36.72 | 982,930 | |
| 37.84 | -1.58 | -4.0% | 39.42 | 39.42 | 37.02 | 1,677,708 | |
| 39.42 | +8.72 | +28.4% | 35.00 | 43.80 | 35.00 | 5,231,218 | |
| 30.70 | -1.38 | -4.3% | 32.00 | 32.00 | 30.14 | 724,796 | |
| 32.08 | -1.30 | -3.9% | 32.20 | 34.38 | 29.20 | 1,360,556 | |
| 33.38 | +0.74 | +2.3% | 32.58 | 33.62 | 32.24 | 248,452 | |
| 32.64 | +0.30 | +0.9% | 32.34 | 33.44 | 32.32 | 165,753 |
- Ticker
- Stockholm:HNSA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
What changed lately
Latest news release · Oct 1, 2026
Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
Latest earnings call · Jul 22, 2026
Hansa Biopharma (Stockholm:HNSA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 22, 2026
Q2 2026 Earnings Presentation
Earnings · 32 slides
Calls
Replays
Hansa Biopharma (Stockholm:HNSA) Q2 2026 Earnings Call
Wed, Jul 22, 2026 · 8:00 AM ET
Watch TranscriptHansa Biopharma (Stockholm:HNSA) Q1 2026 Earnings Call
Thu, Apr 23, 2026 · 8:00 AM ET
Watch TranscriptHansa Biopharma (Stockholm:HNSA) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
Oct 1, 2026
Closed 34.12 (+1.9%) on Oct 1, 2026
Hansa Biopharma Announces New Board Appointments
Sep 24, 2026
Closed 32.22 (-5.2%) on Sep 24, 2026
Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ)
Sep 22, 2026
Closed 34.00 (-4.7%) on Sep 23, 2026
Hansa Biopharma Announces Confidential Submission of Draft Registration Statement to the SEC to allow for a potential Listing of ADSs in the United States
Aug 21, 2026
Closed 41.74 (+2.7%) on Aug 21, 2026
Hansa Biopharma Reports Second Quarter and First Half Year 2026 Financial Results
Jul 22, 2026
Closed 32.08 (-3.9%) on Jul 22, 2026
Financings
Public offering of american Depositary Shares representing ordinary shares, and ordinary shares
Aug 21, 2026
Announced: public offering
Decks
Q2 2026 Earnings Presentation
Earnings · 32 slides · Jul 22, 2026
Investor Presentation (July 2026)
Investor deck · 26 slides · July 2026
Investor Day (June 2026)
Investor day · 64 slides · Jun 25, 2026
Investor Presentation (June 2026)
Investor deck · 28 slides · June 2026
Hansa Biopharma AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 35 in all · newest Oct 1, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Jul 22, 2026
- Decks
- 27 decks · latest Jul 22, 2026
Where Hansa Biopharma AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:HNSA · Home listing · This page | Stockholm | Sweden | SEK |
| LSIN:0RC7 | LSIN | United Kingdom | SEK |
| gettex:24H | gettex | Germany | EUR |
| LS Exchange:A0M65T | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0M65T | Lang & Schwarz | Germany | EUR |
| OTC:HNSBF | OTC | United States | USD |
| Aquis:HNSAS | Aquis | United Kingdom | SEK |
| Aquis:HNSAS | Aquis | United Kingdom | SEK |
| Dusseldorf:24H | Dusseldorf | Germany | EUR |
| Frankfurt:24H | Frankfurt | Germany | EUR |
| Munich:24H | Munich | Germany | EUR |
| Stuttgart:24H | Stuttgart | Germany | EUR |
| Tradegate:24H | Tradegate | Germany | EUR |
| Turquoise:HNSAS | Turquoise | United Kingdom | SEK |
Log in to ask 6ix AI your own questions about Hansa Biopharma AB.